PODD - Hot Stocks: UBER drops on cautious comment; INMB regulatory setback; CTRN rises on earnings; DXCM falls

Uber (NYSE:UBER) was among the standout decliners on an overall weak day for the market, dropping in Tuesday's midday trading following a cautious analyst comment.  INmune Bio (INMB) also suffered an intraday slide, losing around a quarter of its value on a regulatory setback. Meanwhile, Dexcom (DXCM) dropped following reports that it was in talks to acquire Insulet (PODD). Elsewhere in the market, Citi Trends (CTRN) bucked the overall negative trend, rising in intraday action. The rally came after a Street-beating earnings report. Decliners Uber (UBER) lost ground in midday trading, falling about 8% following a cautious comment from Bernstein. Analyst Nikhil Devnani cut his price target on the stock, noting that shares of ride-hailing service had been "beaten up." Although the firm slashed its price target to $35 from $45, Bernstein maintained a bullish outlook long term. The firm kept its Outperform rating and said UBER has been building

For further details see:

Hot Stocks: UBER drops on cautious comment; INMB regulatory setback; CTRN rises on earnings; DXCM falls